21. PWE-085 Immune checkpoint inhibitor induced acute liver injury – a national cohort study. (8th June 2018) Authors: Nathwani, Rooshi; Au, L; Barlow, C; Tillett, T; Bowen, R; Spain, L; Thomas, J; Backhouse, M; Gurung, A; Morrison, R; Cross, T; Herbert, C; Goldin, R; Gore, M; Larkin, J; Turajlic, S; Antoniades, C Journal: Gut Issue: Volume 67(2018)Supplement 1 Page Start: A114 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
22. Recommendations on managing lenvatinib and everolimus in patients with advanced or metastatic renal cell carcinoma. Issue 12 (2nd December 2017) Authors: Grande, E; Glen, H; Aller, J; Argenziano, G; Lamas, MJ; Ruszniewski, P; Zamorano, JL; Edmonds, K; Sarker, S; Staehler, M; Larkin, J Journal: Expert opinion on drug safety Issue: Volume 16:Issue 12(2017:Dec.) Page Start: 1413 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
23. SOCIETY FOR ENDOCRINOLOGY ENDOCRINE EMERGENCY GUIDANCE: Acute management of the endocrine complications of checkpoint inhibitor therapy. Issue 7 (July 2018) Authors: Higham, C E; Olsson-Brown, A; Carroll, P; Cooksley, T; Larkin, J; Lorigan, P; Morganstein, D; Trainer, P J Journal: Endocrine connections Issue: Volume 7:Issue 7(2018) Page Start: G1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗